KTTAW
Pasithea Therapeutics Corp.
Key Financials
Net Income
$-20427683
↓ 46.9%
Gross Profit
$-2213
N/A
Operating Income
$-20857295
↓ 46.4%
Revenue
$486559
↑ 3130.4%
Total Assets
$60.2M
↑ 275.0%
Shareholders' Equity
$55.2M
↑ 273.5%
Cash & Equivalents
$55.2M
↑ 696.8%
Total Liabilities
$5.0M
↑ 291.6%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/16/2026 | View on SEC |
| 25-NSE | 9/16/2026 | View on SEC |
| 8-K | 9/9/2026 | View on SEC |
| 8-K | 8/21/2026 | View on SEC |
| 10-Q | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| ARS | 8/7/2026 | View on SEC |
| DEF 14A | 8/7/2026 | View on SEC |
| SCHEDULE 13G/A | 7/31/2026 | View on SEC |
| PRE 14A | 7/29/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | KTTAW |
| Company Name | Pasithea Therapeutics Corp. |
| CIK | 1841330 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (702) 514-4174 |